Abdullatif Taha Babakr
Overview
Explore the profile of Abdullatif Taha Babakr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babakr A, Nour Eldein M
Explor Target Antitumor Ther
. 2025 Jan;
6():1002284.
PMID: 39781563
Aim: Breast cancer (BC), a disease in which abnormal breast cells grow out of control and form tumors, is a prevalent life-threatening disease worldwide. Oxidative stress has been implicated in...
2.
V H P, Kuruburu M, M K J, Simha N A, Babakr A, Sreenivasan R, et al.
Front Chem
. 2023 Jun;
11:1195209.
PMID: 37265589
Shivagutika is a polyherbal formulation mentioned in Ayurveda, the oldest system of medicine. The aim of this study was to investigate the anti-breast cancer potential of DCM extract of Shivagutika...
3.
Maradesha T, Martiz R, Patil S, Prasad A, Babakr A, Silina E, et al.
PLoS One
. 2023 Jan;
18(1):e0280847.
PMID: 36716329
The current study investigates the effectiveness of phytocompounds from the whole green jackfruit flour methanol extract (JME) against obesity-linked diabetes mellitus using integrated network pharmacology and molecular modeling approach. Through...
4.
Patil S, Phanindra B, Shirahatti P, Martiz R, Sajal H, Babakr A, et al.
J Biomol Struct Dyn
. 2023 Jan;
41(22):13078-13097.
PMID: 36695109
Phytochemical-based drug discovery against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been the focus of the current scenario. In this context, we aimed to perform the phytochemical profiling of...
5.
Elfaki I, Mir R, Duhier F, Alotaibi M, Alalawy A, Barnawi J, et al.
Curr Issues Mol Biol
. 2021 Dec;
43(3):1859-1875.
PMID: 34889890
Type 2 DM (T2D) results from the interaction of the genetic and environmental risk factors. Vascular endothelial growth factor (VEGF), angiotensin I-converting enzyme (ACE), and MicroRNAs (MiRNAs) are involved in...
6.
Mir R, Elfaki I, Duhier F, Alotaibi M, Alalawy A, Barnawi J, et al.
J Pers Med
. 2021 Sep;
11(9).
PMID: 34575638
Type 2 diabetes is a metabolic disease characterized by elevated blood sugar. It has serious complications and socioeconomic impact. The MicroRNAs are short single-stranded and non-coding RNA molecules. They regulate...
7.
Mir R, Elfaki I, Jha C, Javid J, Rehman S, Banu S, et al.
Microrna
. 2020 Dec;
9(5):363-372.
PMID: 33297927
Aim: Apart from the modifiable risk factors, genetic factors are believed to influence the outcome of Coronary Artery Diseases (CAD). Under the genetic factors, miRNA polymorphisms, namely Hsa-miR-146a-5p (rs2910164) have...
8.
Elfaki I, Mir R, Abu-Duhier F, Jha C, Ahmad Al-Alawy A, Babakr A, et al.
Curr Drug Metab
. 2020 Oct;
21(14):1152-1160.
PMID: 33115391
Background: Cytochrome P450s (CYPs) are drug-metabolizing enzymes catalyzing the metabolism of about 75% of drug in clinical use. CYP2C9 represents 20% CYP proteins in liver cells and is a crucial...
9.
Jha C, Mir R, Elfaki I, Javid J, Babakr A, Banu S, et al.
J Pers Med
. 2020 Oct;
10(4).
PMID: 33114503
Coronary artery disease (CAD) is a major cause of death all over the world. CAD is caused by atherosclerosis which is induced by the interaction of genetic factors and environmental...
10.
Abdallah M, El-Readi M, Althubiti M, Adnan Almaimani R, Ismail A, Idris S, et al.
Molecules
. 2020 Jul;
25(15).
PMID: 32722075
Breast cancer is considered as one of the most aggressive types of cancer. Acquired therapeutic resistance is the major cause of chemotherapy failure in breast cancer patients. To overcome this...